• Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
Home
  • Biotech
    • Cell & Gene Therapy
    • Clinical Data
    • Venture Capital
    • Deals
  • Research
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending
    • Biologics
    • Clinical Development
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • CRO Awards
    • Innovation Awards
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
    • Survey
  • Events
  • Subscribe
Home
Trending
Hamburger Menu Hamburger Menu
  • Biotech
    • Cell & Gene Therapy
    • Clinical Data
    • Venture Capital
    • Deals
  • Research
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending
    • Biologics
    • Clinical Development
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • CRO Awards
    • Innovation Awards
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
    • Survey
  • Events
  • Subscribe
  • Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us

89bio

Professional kite surfer soars through the air
Biotech

2 Kite vets fly over to Kyverna Therapeutics—Chutes & Ladders

Two Kite vets fly over to Kyverna Therapeutics. Eyconis eyes Big Pharma vet as CEO. Structure reinforces exec team with promotion and hire.
Darren Incorvaia , Zoey Becker Sep 20, 2024 8:30am
Paragliding over the cliffs Fort Funston San Francisco

BioMarin builds exec team with biotech vets—Chutes & Ladders

Aug 23, 2024 8:30am
paramotor forest Poland

Biogen CMO Maha Radhakrishnan joins Sofinnova—Chutes & Ladders

Aug 9, 2024 8:30am
rocket snail slow leapfrog beat fast win jump over

As Madrigal lands MASH nod, what's next for biotechs in pursuit?

Mar 15, 2024 10:55am
crash fall stock shares market economy down red arrow

Akero's NASH miss drags a few peers down, spurring deja vu

Oct 11, 2023 10:50am
Liver disease

Ex-Novartis drug clears NASH test, fueling pursuit of Akero

Jun 21, 2023 7:15am

Home
  • Connect
    • The Team
    • Advertise
    • Marketing Kit
    • Let's Talk
  • Join Us
    • Newsletters
    • Resources
    • RSS Feeds
  • Our Brands
    • Fierce Pharma
    • Fierce Biotech
    • Fierce Healthcare
  • Our Events
    • Life Sciences Events
©2025 Questex LLC All rights reserved.
Terms of use
Privacy Policy
Privacy Settings